Mostrar el registro sencillo del ítem

dc.contributor.authorCasado, Concepcion 
dc.contributor.authorGalvez, Cristina
dc.contributor.authorPernas, Maria 
dc.contributor.authorTarancon-Diez, Laura
dc.contributor.authorRodriguez, Carmen
dc.contributor.authorSanchez-Merino, Victor 
dc.contributor.authorVera, Mar
dc.contributor.authorOlivares, Isabel 
dc.contributor.authorDe Pablo-Bernal, Rebeca
dc.contributor.authorMerino-Mansilla, Alberto 
dc.contributor.authorDel Romero, Jorge
dc.contributor.authorLorenzo-Redondo, Ramon 
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorSalgado, María
dc.contributor.authorMartinez-Picado, Javier
dc.contributor.authorLopez-Galindez, Luis Cecilio 
dc.date.accessioned2020-02-19T08:16:30Z
dc.date.available2020-02-19T08:16:30Z
dc.date.issued2020-02-05
dc.identifier.citationSci Rep. 2020 Feb 5;10(1):1902.es_ES
dc.identifier.issn2045-2322es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9112
dc.description.abstractElite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define exceptional EC (EEC) as HIV-1 subjects who maintain the EC characteristics without disease progression for more than 25 years. We analyzed three EEC, diagnosed between 1988 and 1992, who never showed signs of clinical disease progression in absence of any antiretroviral treatment. A comprehensive clinical, virological, and immunological study was performed. The individuals simultaneously exhibited ≥3 described host protective alleles, low levels of total HIV-1 DNA (<20 copies/106 CD4+ T-cells) without evidence of replication-competent viruses (<0.025 IUPM), consistent with high levels of defective genomes, strong cellular HIV-1-specific immune response, and a high poly-functionality index (>0.50). Inflammation levels of EEC were similar to HIV-1 negative donors. Remarkably, they showed an exceptional lack of viral evolution and 8-fold lower genetic diversity (<0.01 s/n) in env gene than other EC. We postulate that these EEC represent cases of spontaneous functional HIV-1 cure. A non-functional and non-genetically evolving viral reservoir along with an HIV-1-specific immune response seems to be key for the spontaneous functional cure.es_ES
dc.description.sponsorshipWork in Centro Nacional de Microbiologia (ISCIII) was supported by grants SAF (2016–77894-R) from Ministerio de Economia y Competitividad (MINECO) (Spain) and Fondo de Investigación Sanitaria (FIS)-Instituto de Salud CarlosIII, grant FIS (PI 13/02269, ISCIII) and in part by the RIS-RETIC grants RD12/0017/0028 and RD16CIII/0002/0005 funded by the ISCIII-FEDER. MP has a contract of RIS-RETIC RD16CIII/0002/0005. This work was supported by grants from the MINECO, FIS-Instituto de Salud CarlosIII, Fondos Europeos para el Desarrollo Regional, FEDER, grant numbers PI16/00684, PI19/01127, CPII014/00025 to ER-M. and FI14/00431 to LT-D.; the Gilead Fellowship Program (grant numbers GLD17/00299); the Red de Investigación en Sida (grant number RD16/0025/0020). ER-M. is supported by Consejería de Salud y Bienestar Social of Junta de Andalucía through the Nicolás Monardes Program (C-0032/17). Research in VS-M group was supported by Fondo de Investigación Sanitaria (FIS)-Instituto de Salud CarlosIII, grant FIS (PI 17CIII/00049). Grifols partially supported work in the AIDS Research Institute IrsiCaixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titlePermanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous curees_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID32024974es_ES
dc.format.volume10es_ES
dc.format.number1es_ES
dc.format.page1902es_ES
dc.identifier.doi10.1038/s41598-020-58696-yes_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) 
dc.contributor.funderRed de Investigación Cooperativa en Investigación en Sida (España) 
dc.contributor.funderRegional Government of Andalusia (España) 
dc.description.peerreviewedes_ES
dc.identifier.e-issn2045-2322es_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41598-020-58696-yes_ES
dc.identifier.journalScientific reportses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/2016–77894-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI 13/02269es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0017/0028es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0005es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI16/00684es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI19/01127es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CPII014/00025es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FI14/00431es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/GLD17/00299es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16/0025/0020es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/C-0032/17es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI 17CIII/00049es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional